We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights: Cigna, EOG Resources, Northrop Grumman, Sherwin-Williams and Eaton
Read MoreHide Full Article
For Immediate Release
Chicago, IL – May 10, 2019 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Cigna (CI - Free Report) , EOG Resources (EOG - Free Report) , Northrop Grumman (NOC - Free Report) , Sherwin-Williams (SHW - Free Report) and Eaton Corp (ETN - Free Report) .
Here are highlights from Thursday’s Analyst Blog:
Top Research Reports for Cigna, EOG Resources and Northrop Grumman
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Cigna, EOG Resources and Northrop Grumman. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
Cigna’s shares have lost -8.5% over the past year, underperforming the Zacks Multi-Line Insurance industry, which has declined -1.2% over the same period. However, Cigna’s first-quarter earnings surpassed expectations by 4.3% but declined 5.1% year over year. The Zacks analyst thinks Cigna’s acquisition of Express Scripts is likely to fuel long-term growth.
The company’s expanding international business provides diversification. Its group disability and other businesses are expected to perform well, led by personalized and affordable solutions. Its growing membership has aided revenue growth.
Along with top-line growth, Cigna has been able to maintain bottom-line profitability as well. Its strong capital position enables investment in business. An increase in leverage might pose financial risks. Rise in operating expenses may weigh on margins.
Shares of Buy-ranked EOG Resources have declined -21% over the past year, outperforming the Zacks Oil & Gas E&P Industry, which has slumped -33.5% over the same period. EOG Resources holds premium acreages in the Permian, Bakken and Eagle Ford shale plays, among others, where it has identified 9,500 premium undrilled wells that could lend access to 9.2 billion barrels of oil equivalent estimated potential reserves.
In the Eagle Ford alone, EOG Resources has identified 2,300 locations that will drive the firm’s oil production. The Zacks analyst likes the fact that the company has been focused on consistently returning cash to shareholders.
Taking into account the latest quarterly dividend hike, the upstream energy player has managed to hike dividend payments by almost 72% since 2017. Notably, the upstream energy firm recently reported strong first-quarter 2019 earnings, thanks to higher oil equivalent production volumes. Moreover, the company emphasizes on reducing cash operating expenses and expects to lower costs through 2019, thereby boosting its bottom line.
Buy-ranked Northrop Grumman’s shares have underperformed the Zacks Aerospace Defense industry over the past year, losing -11% over the period versus the industry’s -1.4% decline. Northrop Grumman ended first-quarter 2019 on a mixed note. While its earnings surpassed expectations, revenues missed the consensus mark. However, results remained impressive on a year-over-year basis.
The Zacks analyst likes the fact that as a major U.S. defense contractor, Northrop Grumman continues to enjoy a strong position in the Air Force, Space & Cyber Security programs. In a bid to boost its growth trajectory, Northrop Grumman completed the acquisition of rocket-maker Orbital ATK for $9.2 billion last year. Increasing international opportunities are expected to boost the company’s margin growth.
Currently, the company is getting ready to move into full-rate production for Triton. However, it continues to incur high operating expenses on account of increasing product costs. This may disappoint investors.
Other noteworthy reports we are featuring today include Sherwin-Williams and Eaton Corp.
This Could Be the Fastest Way to Grow Wealth in 2019
Research indicates one sector is poised to deliver a crop of the best-performing stocks you'll find anywhere in the market. Breaking news in this space frequently creates quick double- and triple-digit profit opportunities.
These companies are changing the world – and owning their stocks could transform your portfolio in 2019 and beyond. Recent trades from this sector have generated +98%, +119% and +164% gains in as little as 1 month.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performancef or information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights: Cigna, EOG Resources, Northrop Grumman, Sherwin-Williams and Eaton
For Immediate Release
Chicago, IL – May 10, 2019 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Cigna (CI - Free Report) , EOG Resources (EOG - Free Report) , Northrop Grumman (NOC - Free Report) , Sherwin-Williams (SHW - Free Report) and Eaton Corp (ETN - Free Report) .
Here are highlights from Thursday’s Analyst Blog:
Top Research Reports for Cigna, EOG Resources and Northrop Grumman
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Cigna, EOG Resources and Northrop Grumman. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Cigna’s shares have lost -8.5% over the past year, underperforming the Zacks Multi-Line Insurance industry, which has declined -1.2% over the same period. However, Cigna’s first-quarter earnings surpassed expectations by 4.3% but declined 5.1% year over year. The Zacks analyst thinks Cigna’s acquisition of Express Scripts is likely to fuel long-term growth.
The company’s expanding international business provides diversification. Its group disability and other businesses are expected to perform well, led by personalized and affordable solutions. Its growing membership has aided revenue growth.
Along with top-line growth, Cigna has been able to maintain bottom-line profitability as well. Its strong capital position enables investment in business. An increase in leverage might pose financial risks. Rise in operating expenses may weigh on margins.
Shares of Buy-ranked EOG Resources have declined -21% over the past year, outperforming the Zacks Oil & Gas E&P Industry, which has slumped -33.5% over the same period. EOG Resources holds premium acreages in the Permian, Bakken and Eagle Ford shale plays, among others, where it has identified 9,500 premium undrilled wells that could lend access to 9.2 billion barrels of oil equivalent estimated potential reserves.
In the Eagle Ford alone, EOG Resources has identified 2,300 locations that will drive the firm’s oil production. The Zacks analyst likes the fact that the company has been focused on consistently returning cash to shareholders.
Taking into account the latest quarterly dividend hike, the upstream energy player has managed to hike dividend payments by almost 72% since 2017. Notably, the upstream energy firm recently reported strong first-quarter 2019 earnings, thanks to higher oil equivalent production volumes. Moreover, the company emphasizes on reducing cash operating expenses and expects to lower costs through 2019, thereby boosting its bottom line.
Buy-ranked Northrop Grumman’s shares have underperformed the Zacks Aerospace Defense industry over the past year, losing -11% over the period versus the industry’s -1.4% decline. Northrop Grumman ended first-quarter 2019 on a mixed note. While its earnings surpassed expectations, revenues missed the consensus mark. However, results remained impressive on a year-over-year basis.
The Zacks analyst likes the fact that as a major U.S. defense contractor, Northrop Grumman continues to enjoy a strong position in the Air Force, Space & Cyber Security programs. In a bid to boost its growth trajectory, Northrop Grumman completed the acquisition of rocket-maker Orbital ATK for $9.2 billion last year. Increasing international opportunities are expected to boost the company’s margin growth.
Currently, the company is getting ready to move into full-rate production for Triton. However, it continues to incur high operating expenses on account of increasing product costs. This may disappoint investors.
Other noteworthy reports we are featuring today include Sherwin-Williams and Eaton Corp.
This Could Be the Fastest Way to Grow Wealth in 2019
Research indicates one sector is poised to deliver a crop of the best-performing stocks you'll find anywhere in the market. Breaking news in this space frequently creates quick double- and triple-digit profit opportunities.
These companies are changing the world – and owning their stocks could transform your portfolio in 2019 and beyond. Recent trades from this sector have generated +98%, +119% and +164% gains in as little as 1 month.
Click here to see these breakthrough stocks now >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
http://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performancef or information about the performance numbers displayed in this press release.